Received Jun 20, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MMR | MEASLES + MUMPS + RUBELLA (MMR II) | MERCK & CO. INC. | UNK | — | — |
the patient developed an Alpha-Gal allergy at an unknown point in time; but it is not showing when they ran titers; This spontaneous report was received from a Nurse and refers to an 60-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions included Prednisone allergy, Penicillin allergy, and Alpha-Gal allergy. Historical drugs included Prednisone (Prednisone), and Penicillin (Penicillin nos). Concomitant therapies were not reported. On an unknown date, it was stated that the patient was vaccinated with the series of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II), injection 0.5 mL, administered as prophylaxis (Lot Numbers, expiration dates, dose numbers, exact dose quantity volumes, routes and anatomical locations of administrations and vaccination scheme frequencies were not provided); that were reconstituted with sterile diluent (Lot No, expiration date and indication were not provided). On an unknown date, the patient developed an alpha-Gal allergy (food allergy) and also it was stated that she received the measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (MMR II) series (dates unknown) but it is not showing when they ran titers (antibody test negative) At the reporting time, the outcome of both events was not provided. The causal relationship between the both events with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and the sterile diluent was not provided.
Alpha-gal allergy; Drug allergy; Penicillin allergy
DILUENT MRK